2,3-dihydroxyquinoxaline has been researched along with oleanolic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelsamie, AS; Atta, MH; El Diwani, HI; Elhefnawi, MM; Galal, SA; Lida, A; Ramadan, RA; Suzuki, N; Tokuda, H | 1 |
| Abdelsamie, AS; Ali, MM; El Diwani, HI; Galal, SA; Lida, A; Mortier, J; Ramadan, RA; Soliman, SM; Suzuki, N; Tokuda, H; Wolber, G | 1 |
2 other study(ies) available for 2,3-dihydroxyquinoxaline and oleanolic acid
| Article | Year |
|---|---|
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives.
Topics: Animals; Antigens, Viral; Antineoplastic Agents; Binding Sites; Drug Design; Female; Hydrogen Bonding; Mice; Models, Molecular; Neoplasms; Protein Conformation; Proto-Oncogene Proteins c-kit; Quinoxalines; Reproducibility of Results | 2011 |
Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor.
Topics: Antigens, Viral; Antineoplastic Agents; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Hep G2 Cells; Humans; MCF-7 Cells; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Quinoxalines; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship | 2013 |